Citations
32 citation(s) found for "Meng, Wei".
Faculty Opinions recommendation of Both leukaemic and normal peripheral B lymphoid cells are highly sensitive to the selective pharmacological inhibition of prosurvival Bcl-2 with ABT-199.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available